Clinical Trial Update: Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating liposomal SN-38 in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Liposomal SN-38 (liposomal SN-38)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED